Spark Investment Management’s Heron Therapeutics HRTX Stock Holding History

Spark Investment Management’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-65,600	Closed	-$770K	–	158
2020 Q1	$770K	Hold	65,600	–	–	0.41%	79
2019 Q4	$1.54M	Hold	65,600	–	–	0.18%	166
2019 Q3	$1.21M	Buy	65,600 +33,000	+101%	+$607K	0.16%	164
2019 Q2	$606K	Buy	+32,600	New	+$651K	0.04%	354
2015 Q4	–	Sell	-17,500	Closed	-$427K	–	793
2015 Q3	$427K	Hold	17,500	–	–	0.06%	402
2015 Q2	$545K	Buy	+17,500	New	+$329K	0.08%	340
2014 Q4	–	Sell	-15,500	Closed	-$129K	–	740
2014 Q3	$129K	Sell	15,500 -14,100	-48%	-$131K	0.02%	564
2014 Q2	$364K	Buy	+29,600	New	+$354K	0.05%	406

Other funds holding HRTX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Spark Investment Management's HRTX Position: Q2 2020 in Review

Spark Investment Management sold out of Heron Therapeutics (HRTX) in Q2 2020, closing a stake of 65,600 shares — an estimated $770K sold.

Spark Investment Management first reported a position in HRTX in Q2 2014 and held it in 8 quarters. The position peaked at $1.54M in Q4 2019. 190 funds tracked by Wall St. Rank hold HRTX as of Q2 2020.

Spark Investment Management reported no remaining Heron Therapeutics position as of Q2 2020 after selling out during the quarter.
Spark Investment Management sold 65,600 Heron Therapeutics shares in Q2 2020, an estimated $770K.
Spark Investment Management first reported a position in Heron Therapeutics in Q2 2014 and held it in 8 quarters.
Spark Investment Management's Heron Therapeutics position peaked at $1.54M in Q4 2019.
190 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2020.

Based on Spark Investment Management's 13F filing for Q2 2020, filed 12 Aug 2020.